Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Down 70.7% in July

Lonza Group Ag (OTCMKTS:LZAGY) saw a significant drop in short interest in July. As of July 31st, there was short interest totaling 16,610 shares, a drop of 70.7% from the July 15th total of 56,620 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 100,225 shares, the short-interest ratio is currently 0.2 days.

Lonza Group Stock Performance

Shares of LZAGY stock opened at $69.57 on Thursday. The company’s fifty day simple moving average is $67.38 and its two-hundred day simple moving average is $65.63. Lonza Group has a 52 week low of $58.53 and a 52 week high of $73.85. The company has a current ratio of 2.24, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.